Stanley Iyadurai
Chief Tech/Sci/R&D Officer at CATALYST PHARMACEUTICALS, INC.
Stanley Iyadurai active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-08-19 | - |
Career history of Stanley Iyadurai
Former positions of Stanley Iyadurai
| Companies | Position | Start | End |
|---|---|---|---|
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 2017-06-30 | 2018-06-30 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Training of Stanley Iyadurai
| University of Minnesota | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Stock Market
- Insiders
- Stanley Iyadurai
- Experience
